Literature DB >> 953903

Tartrazine-containing drugs.

W R Bartle.   

Abstract

Pharmaceutical manufacturers producing or distributing drugs in Canada were surveyed between December 1974 and March 1975 to determine which of their products contained tartrazine, a pyrazole aniline dye. A list of some 580 drug products of the 156 manufacturers who responded is presented for aid in managing the tartrazine-sensitive patients.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 953903      PMCID： PMC1878658     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  5 in total

Review 1.  Drug therapy. During allergy (third of three parts).

Authors:  C W Parker
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

2.  Urticaria induced by preservatives and dye additives in food and drugs.

Authors:  G Michaëlsson; L Juhlin
Journal:  Br J Dermatol       Date:  1973-06       Impact factor: 9.302

3.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Authors:  M Samter; R F Beers
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

4.  Response of aspirin-allergic patients to challenge by some analgesics in common use.

Authors:  A P Smith
Journal:  Br Med J       Date:  1971-05-29

5.  Aspirin allergy: a clinical study.

Authors:  F Speer
Journal:  South Med J       Date:  1975-03       Impact factor: 0.954
  5 in total
  3 in total

1.  Reactions to acetylsalicylic acid.

Authors:  T H Aaron; E L Muttitt
Journal:  Can Med Assoc J       Date:  1982-03-15       Impact factor: 8.262

2.  Use of drugs with dependence liability.

Authors:  M S Jacob; E M Sellers
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

3.  Tartrazine: a potentially hazardous dye in Canadian drugs.

Authors:  M E MacCara
Journal:  Can Med Assoc J       Date:  1982-04-15       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.